http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2015102278-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-69 |
| filingDate | 2013-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2015102278-A |
| titleOfInvention | COMPOUNDS AND THEIR THERAPEUTIC USE |
| abstract | 1. A compound having a structure according to Formula Ia also its pharmaceutically acceptable salts and solvates; where: X is a pharmaceutically acceptable counterion; Y is —CHCHO—, —CHO—, —OCH—, —SCH—, —N (R) CH-, -N (R) C (= O) -, -C (= O) N (R) -, -S (= O) CH-, -S (= O) CH-, -CHCHO-, - CHS-, -CHN (R) -, -CHS (= O) -, -CHS (= O) -, -C (= O) O-, -OC (= O) -, -SON (R) -, -N (R) SO-, ethylene, propylene, n-butylene, -O-Ci-alkylene-N (R) C (= O) -, -O-Ci-alkylene-C (= O) N (R) -, -N (R) C (= O) -Calkylene-O-, -C (= O) N (R) -Calkylene-O-, -Calkylene-S (= O) -, -Calkylene-S (= O) -, -S (= O) -Calkylene-, -S (= O) -Calkylene-, -Calkylene-SON (R) -, -Calkylene-N (R) SO-, -SON (R) -Calkylene-, -N (R) SO-Calkylene-, -Calkylene-O-Calkylene-, -O-Calkylene-, -Calkylene-O-, -S-Calkyl n-, -Calkylene-S-, -Calkylene-S-Calkylene-, -N (R) -Calkylene-, -Calkylene-N (R) -, -Calkylene-N (R) -Calkylene-, -Calkylene-C (= O) -O-Calkylene-, -Calkylene-OC (= O) -Calkylene-, -Calkylene-C (= O) -N (R) -Calkylene-, -Calkylene-N (R) -C (= O) -Calkylene-, -C (= O) -N (R) -Calkylene-SON (R) - or -N (R) -C (= O) -Calkylene-SON (R) -; R and R, if one or both are present one or more times, each independently selected from halo, C 1-6 alkyl, nitro, cyano, C 1 alkoxy, C-amido, N-amido, trihalomethyl, C-carboxy, O-carboxy, sulfonamide, amino, aminoalkyl, hydroxyl, mercapto, alkylthio, sulfonyl and sulfinyl, where C 1-6 alkyl, C 1 alkoxy, C-amido, N-amido, amino, aminoalkyl and alkylthio groups are each optionally substituted with a heterocycle, cycloalkyl or amino group; R, if present one or more times, is independently selected from halo, C1-6alkyl, nitro, cyano, Calkoxy, C-amido, N-amido, trihalomethyl, C-carboxy, O-carboxy , sulfonamide, amino, hydroxyl, mercapto, alkylthio, sulfonyl and sulfinyl groups; R, if present one or more times, is attached only to the ring carbon atom and is independently selected from halo, C1-6alkyl, nitro, cyano, Calkoxy, C-amido , N-amido, trihalomethyl, C-carboxy, O-carboxy , sulfonamide, amino, hydroxyl, mercapto, alkylthio, sulfonyl and sulfinyl groups; A is optionally present and, if present, is selected from O, S, N (R), N (R) -Calkylene and Calkylene; R is selected from hydro- , C1-6alkyl, C1-6alkenyl, C1-6alkynyl, |
| priorityDate | 2012-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 152.